CompoAtlas

Biotin Plus

Natural health product licensed in Canada

Licence holder
Mapleland Enterprises Inc.
NPN or DIN-HM
80121396
Status
Active licence
Licence date
3 October 2022
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Officinale

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Biotine

Source : Biotine

500 mcg500 µg
Zinc

Source : Diglycinate de zinc

4 mg4,000 µg
Vitamine C

Source : Acide ascorbique

200 mg200,000 µg
Vitamine E

Source : d-alpha tocophérol

24 mg ATNot calculated

Non-medicinal ingredients

Hypromellose, Cellulose microcristalline, Stéarate de magnésium

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Capsule1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps to maintain/support healthy hair/nail/mucous membranes/(and) skin. Helps to maintain/support immune function/the immune system. Source of/Provides an antioxidant that protects the fat in body tissues from oxidation.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80121396

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line